NPI: 1982671004 · LEESBURG, FL 34788 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/07/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/07/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 12,761 | $1.61M |
| 2019 | 10,561 | $2.19M |
| 2020 | 13,820 | $2.14M |
| 2021 | 4,541 | $438K |
| 2022 | 2,253 | $154K |
| 2023 | 687 | $17K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 15,369 | 1,148 | $2.27M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 14,998 | 745 | $1.99M |
| J1270 | Injection, doxercalciferol, 1 mcg | 5,869 | 482 | $978K |
| J1756 | Injection, iron sucrose, 1 mg | 2,643 | 574 | $324K |
| A4657 | Syringe, with or without needle, each | 1,309 | 868 | $285K |
| 85048 | 939 | 698 | $152K | |
| 85041 | 934 | 698 | $152K | |
| 83970 | 674 | 531 | $114K | |
| 83540 | 552 | 418 | $82K | |
| 83550 | 527 | 403 | $78K | |
| 82728 | 506 | 372 | $77K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 213 | 103 | $33K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 57 | 46 | $11K |
| 90674 | 19 | 16 | $4K | |
| G0008 | Administration of influenza virus vaccine | 14 | 12 | $2K |